newsfilter.io

Michael Brandt

Showing 1–2 of 2 transcripts.

  1. Sourcery with Molly O'Shea47 min

    The Wildest Hot Takes From the All-In Summit 2026

    Elon Musk, Jensen Huang, Satya Nadella, Gwynne Shotwell, Jared Isaacman, Brad Gerstner, Bill Gurley, Dina Powell McCormick, Jake Paul, Nick Shirley, Blake Scholl, Martin Shkreli, Chamath Palihapitiya, Jason Calacanis, David Sacks, David Friedberg, Naveen Rao, Jonathan Neman, Toby Rice, Wen Sang, Geoff Woo, Kent Draper, Michael Brandt, Molly

    Industry leaders including Jensen Huang, Elon Musk, and Naveen Rao reached a pragmatic consensus on AI governance that prioritizes independent peer review and hardware efficiency over existential risk narratives or development halts. The dialogue highlighted a critical pivot toward solving energy constraints through massive infrastructure expansion and ultra-efficient computing to prevent a "SaaS apocalypse" while democratizing access via no-code agents. Concurrently, the speakers addressed broader economic and societal implications, warning that political interference in energy markets and outdated regulatory frameworks pose immediate threats to both AI scaling and public infrastructure projects.

  2. a16z23 min

    a16z Podcast | Nootropics and the Best Version of Your Brain, Yourself

    Geoffrey Woo, Michael Brandt, Kyle Russell, Jeffrey Wu, Sakantala Pansaratne

    Founders of NutriBox are positioning their company as a clinical bridge between amateur biohacking and mainstream cognitive enhancement by deploying MD-PhD teams to verify nootropic formulations through double-blind trials. This venture challenges the supplement industry's opaque "proprietary blend" model with open-source ingredient ratios and is expanding beyond standard pills into novel formats like "Go Cubes" and personalized data-driven stacks. The founders predict this rigorous approach will catalyze a new wave of billion-dollar human enhancement firms that democratize access to optimal cognitive baselines without relying on traditional pharmaceutical patents.